Transcranial ExAblate
Transcranial ExAblate is a medical device with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound
ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease
ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors
Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors
Feasibility Study of ExAblate Thalamotomy for Treatment of Chronic Trigeminal Neuropathic Pain
Clinical Trials (5)
Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound
ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease
ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors
Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors
Feasibility Study of ExAblate Thalamotomy for Treatment of Chronic Trigeminal Neuropathic Pain
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5